{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T15:53:12Z","timestamp":1787932392821,"version":"build-2784847793"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005743","name":"Universit\u00e0 Cattolica del Sacro Cuore","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005743","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Following the SARS-CoV-2 pandemic, a significant percentage of people are now experiencing long-term symptoms, despite a continuing lack of concrete documentation of physiological and risk profiles that hinders diagnosis and treatment, particularly in pediatric contexts. This review aims to highlight the existing evidence for measurable physiological markers for post-acute sequelae of SARS-CoV-2 infection (long COVID) in children, adolescents, and young adults. Titles providing data related to measurable biomarkers distinguishing young long COVID patients from controls were compiled and analyzed. Results were displayed in table and diagram form for optimal qualitative evaluation of the relationship between markers and symptomatology within the context of each organ system. Only human studies published in English, Italian, Portuguese, German, and Spanish between the 5th of February 2025 and the 31st of December 2025 were considered, and no other time constraints were applied. Following search and criteria evaluation, nine studies were included, totaling 41 occurrences identified in diseased patients with statistically significant variation from healthy controls. Markers suggest the presence of organic manifestations based on published literature, although more data and future studies will be necessary to establish clear connections.<\/jats:p>\n                  <jats:p>\n                    <jats:italic>Conclusion<\/jats:italic>\n                    : The data compiled for this review adds to the body of evidence indicating a physiological manifestation of long COVID and its consequences. Further investigation into potential risk factors, pre- and post-pubescent manifestations, and specific inflammatory and immune pathways will be necessary for a more concrete understanding of long COVID and its effects on children, adolescents, and young adults.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:table-wrap>\n                      <jats:table>\n                        <jats:tbody>\n                          <jats:tr>\n                            <jats:td colspan=\"2\">\n                              <jats:bold>What is Known:<\/jats:bold>\n                              \u2022\n                              <jats:italic>Long COVID is estimated to affect a significant population of patients, despite the lack of concrete physiological diagnostic and prognostic measures<\/jats:italic>\n                              .\u2022\n                              <jats:italic>Pediatric incidence of the disease is still largely debated, and published data are scarce<\/jats:italic>\n                              .\n                            <\/jats:td>\n                          <\/jats:tr>\n                          <jats:tr>\n                            <jats:td colspan=\"2\">\n                              <jats:bold>What is New:<\/jats:bold>\n                              \u2022\n                              <jats:italic>A total of 41 biomarker occurrences were identified by selected studies, which were consistent with expected physiology behind reported symptoms<\/jats:italic>\n                              .\u2022\n                              <jats:italic>The body of data discussed suggests the presence of physiological phenomena behind the long-term symptoms experienced by pediatric long- COVID patients<\/jats:italic>\n                              .\n                            <\/jats:td>\n                          <\/jats:tr>\n                        <\/jats:tbody>\n                      <\/jats:table>\n                    <\/jats:table-wrap>\n                  <\/jats:p>","DOI":"10.1007\/s00431-026-06789-7","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T09:31:19Z","timestamp":1771234279000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Biomarkers of long COVID in children and young adults: a scoping review"],"prefix":"10.1007","volume":"185","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9579-3768","authenticated-orcid":false,"given":"Bettina","family":"Camara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8567-2639","authenticated-orcid":false,"given":"Danilo","family":"Buonsenso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,16]]},"reference":[{"key":"6789_CR1","unstructured":"World Health Organization (2021) A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021 (WHO\/2019-nCoV\/Post_COVID-19_condition\/Clinical_case_definition\/2021.1). World Health Organization, Geneva. https:\/\/www.who.int\/publications\/i\/item\/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1. Accessed 1 Dec 2025"},{"key":"6789_CR2","unstructured":"World Health Organization (2025) Coronavirus (COVID-19) cases dashboard. World Health Organization, Geneva. https:\/\/data.who.int\/dashboards\/covid19\/cases (accessed 12 March 2025)"},{"key":"6789_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43661-w","volume":"14","author":"CE Hastie","year":"2023","unstructured":"Hastie CE, Lowe DJ, McAuley A, Mills NL, Winter AJ, Black C, Scott JT, O\u2019Donnell CA, Blane DN, Browne S, Ibbotson TR, Pell JP (2023) True prevalence of long-COVID in a nation-wide population cohort study. Nat Commun 14:7892. https:\/\/doi.org\/10.1038\/s41467-023-43661-w","journal-title":"Nat Commun"},{"key":"6789_CR4","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1007\/s00431-023-05360-y","volume":"183","author":"N Toepfner","year":"2024","unstructured":"Toepfner N, Brinkmann F, Augustin S, Stojanov S, Behrends U (2024) Long COVID in pediatrics\u2014epidemiology, diagnosis and management. Eur J Pediatr 183:1543\u20131553. https:\/\/doi.org\/10.1007\/s00431-023-05360-y","journal-title":"Eur J Pediatr"},{"key":"6789_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102815","volume":"76","author":"A Camporesi","year":"2024","unstructured":"Camporesi A, Morello R, La Rocca A, Zampino G, Vezzulli F, Munblit D, Raffaelli F, Valentini P, Buonsenso D (2024) Characteristics and predictors of long COVID in children: a 3-year prospective cohort study. EClinicalMedicine 76:102815. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102815","journal-title":"EClinicalMedicine"},{"key":"6789_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/children12010028","volume":"12","author":"M Floridia","year":"2025","unstructured":"Floridia M, Buonsenso D, Macculi L, Weimer LE, Giuliano M, Pricci F, Bianchi L, Toraldo DM, Onder G, ISS Long-COVID Study Group (2025) Adolescents with persistent symptoms following acute SARS-CoV-2 infection (long-COVID): symptom profile, clustering and follow-up. Children 12:28. https:\/\/doi.org\/10.3390\/children12010028","journal-title":"Children"},{"key":"6789_CR7","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.39444","volume":"7","author":"MG Miller","year":"2024","unstructured":"Miller MG, Terebuh P, Kaelber DC, Xu R, Davis PB (2024) SARS-CoV-2 infection and new-onset type 2 diabetes among pediatric patients, 2020 to 2022. JAMA Netw Open 7:e2439444. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.39444","journal-title":"JAMA Netw Open"},{"key":"6789_CR8","doi-asserted-by":"publisher","first-page":"492","DOI":"10.5114\/reum\/176464","volume":"61","author":"O Boyarchuk","year":"2023","unstructured":"Boyarchuk O, Volianska L (2023) Autoimmunity and long COVID in children. Reumatologia 61:492\u2013501. https:\/\/doi.org\/10.5114\/reum\/176464","journal-title":"Reumatologia"},{"key":"6789_CR9","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s15010-024-02394-8","volume":"53","author":"F Ehm","year":"2025","unstructured":"Ehm F, Tesch F, Menzer S, Loser F, Bechmann L, Vivirito A, Wende D, Batram M, Buschmann T, Ludwig M, Roessler M, Seifert M, Sarganas Margolis G, Reitzle L, Koenig C, Schulte C, Ballesteros P, Bassler S, Bitterer T, Riederer C (2025) Long\/post-COVID in children and adolescents: symptom onset and recovery after one year based on healthcare records in Germany. Infection 53:415\u2013426. https:\/\/doi.org\/10.1007\/s15010-024-02394-8","journal-title":"Infection"},{"key":"6789_CR10","doi-asserted-by":"publisher","unstructured":"RECOVER Consortium (2024) Post-acute and chronic kidney function outcomes of COVID-19 in children and adolescents: an EHR cohort study. medRxiv. 2024.06.25.24309488. https:\/\/doi.org\/10.1101\/2024.06.25.24309488","DOI":"10.1101\/2024.06.25.24309488"},{"key":"6789_CR11","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.33454","volume":"5","author":"AL Sorg","year":"2022","unstructured":"Sorg AL, Becht S, Jank M, Armann J, von Both U, Hufnagel M, Lander F, Liese JG (2022) Association of SARS-CoV-2 seropositivity with myalgic encephalomyelitis\/chronic fatigue syndrome among children and adolescents in Germany. JAMA Netw Open 5:e2233454. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.33454","journal-title":"JAMA Netw Open"},{"key":"6789_CR12","doi-asserted-by":"publisher","first-page":"S139","DOI":"10.1016\/j.jaci.2023.11.712","volume":"153","author":"S Petersen","year":"2024","unstructured":"Petersen S (2024) Diagnostic and immunological features of post-COVID-19 postural orthostatic tachycardia syndrome in children. J Allergy Clin Immunol 153:S139. https:\/\/doi.org\/10.1016\/j.jaci.2023.11.712","journal-title":"J Allergy Clin Immunol"},{"key":"6789_CR13","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2023-062570","volume":"153","author":"S Rao","year":"2024","unstructured":"Rao S, Gross RS, Mohandas S, Stein CR, Case A, Dreyer B, Pajor NM, Bunnell HT, Warburton D, Berg E, Overdevest JB, Gorelik M, Milner J, Saxena S, Jhaveri R, Wood JC, Rhee KE, Letts R, Maughan C, Guthe N (2024) Post-acute sequelae of SARS-CoV-2 in children. Pediatrics 153:e2023062570. https:\/\/doi.org\/10.1542\/peds.2023-062570","journal-title":"Pediatrics"},{"key":"6789_CR14","doi-asserted-by":"publisher","unstructured":"PRISMA-ScR Methodology Group (2020) Chapter 11: scoping reviews. In: Aromataris E, Munn Z (eds) JBI manual for evidence synthesis. JBI. https:\/\/doi.org\/10.46658\/JBIMES-20-12","DOI":"10.46658\/JBIMES-20-12"},{"key":"6789_CR15","doi-asserted-by":"publisher","unstructured":"Peters MDJ, Godfrey C, McInerney P, Munn Z, Tricco AC, Khalil H (2020) Updated methodological guidance for the conduct of JBI scoping reviews. JBI Manual for Evidence Synthesis. https:\/\/doi.org\/10.46658\/JBIMES-20-12","DOI":"10.46658\/JBIMES-20-12"},{"key":"6789_CR16","doi-asserted-by":"publisher","unstructured":"Open Science Framework (2021) OSF registration \u201cTNGYW: paediatric long-COVID prospective cohort protocol.\u201d https:\/\/doi.org\/10.17605\/OSF.IO\/TNGYW","DOI":"10.17605\/OSF.IO\/TNGYW"},{"key":"6789_CR17","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1136\/jech.52.6.377","volume":"52","author":"SH Downs","year":"1998","unstructured":"Downs SH, Black N (1998) The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health 52:377\u2013384. https:\/\/doi.org\/10.1136\/jech.52.6.377","journal-title":"J Epidemiol Community Health"},{"key":"6789_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1396263","volume":"14","author":"SD Tyrkalska","year":"2024","unstructured":"Tyrkalska SD, P\u00e9rez-Sanz F, Franco-Mart\u00ednez L, Rubio CP, Tvarijonaviciute A, Mart\u00ednez-Subiela S, M\u00e9ndez-Hern\u00e1ndez M, Gonz\u00e1lez-Aumatell A, Carreras-Abad C, Dom\u00e8nech-Mar\u00e7al \u00c8, Cer\u00f3n JJ, Cayuela ML, Mulero V, Candel S (2024) Salivary biomarkers as pioneering indicators for diagnosis and severity stratification of pediatric long COVID. Front Cell Infect Microbiol 14:1396263. https:\/\/doi.org\/10.3389\/fcimb.2024.1396263","journal-title":"Front Cell Infect Microbiol"},{"key":"6789_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41390-025-03837-0","author":"D Buonsenso","year":"2025","unstructured":"Buonsenso D, Cotugno N, Amodio D, Pascucci GR, Di Sante G, Pighi C, Morrocchi E, Pucci A, Olivieri G, Colantoni N, Romani L, Rotili A, Neri A, Morello R, Sali M, Tremoulet A, Raffaelli F, Zampino G, Rossi P, Valentini P (2025) Distinct pro-inflammatory\/pro-angiogenetic signatures distinguish children with long COVID from controls. Pediatr Res. https:\/\/doi.org\/10.1038\/s41390-025-03837-0","journal-title":"Pediatr Res"},{"key":"6789_CR20","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1097\/INF.0000000000004558","volume":"44","author":"D Buonsenso","year":"2025","unstructured":"Buonsenso D, Camporesi A, Di Sante G, Sali M, Pereyra MDC, Morello R, Valentini P, Raffaelli F, Rodriguez L, Gonzalez L, Johnsson A, Habimana CM, Lakshmikanth T, Brodin P (2025) Cytokine profile in children following SARS-CoV-2 infection: preliminary findings. Pediatr Infect Dis J 44:54\u201357","journal-title":"Pediatr Infect Dis J"},{"issue":"12","key":"6789_CR21","doi-asserted-by":"publisher","first-page":"e430","DOI":"10.1097\/INF.0000000000004470","volume":"43","author":"D Buonsenso","year":"2024","unstructured":"Buonsenso D, Sorrentino S, Ferretti A, Morello R, Valentini P, Di Gennaro L, De Candia E (2024) Circulating activated platelets in children with long COVID: a case-controlled preliminary observation. Pediatr Infect Dis J 43(12):e430\u2013e433. https:\/\/doi.org\/10.1097\/INF.0000000000004470","journal-title":"Pediatr Infect Dis J"},{"key":"6789_CR22","first-page":"7695","volume":"26","author":"D G\u00fcven","year":"2022","unstructured":"G\u00fcven D, Bulu\u015f AD (2022) Clinical and laboratory predictors of long-COVID in children: a single-center retrospective study. Eur Rev Med Pharmacol Sci 26:7695\u20137704","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"6789_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-23168-y","volume":"12","author":"L Di Gennaro","year":"2022","unstructured":"Di Gennaro L, Valentini P, Sorrentino S, Ferretti MA, De Candia E, Basso M, Lancellotti S, De Cristofaro R, De Rose C, Mariani F, Morello R, Lazzareschi I, Sigfrid L, Munblit D, Buonsenso D (2022) Extended coagulation profile of children with long COVID: a prospective study. Sci Rep 12:18392. https:\/\/doi.org\/10.1038\/s41598-022-23168-y","journal-title":"Sci Rep"},{"key":"6789_CR24","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/s41390-024-03731-1","volume":"98","author":"F Kov\u00e1cs","year":"2025","unstructured":"Kov\u00e1cs F, Posvai T, Zs\u00e1ry E, Kolonics F, Garai R, Herczeg V, Cz\u00e1r\u00e1n D, Tak\u00e1cs J, Szab\u00f3 AJ, Kriv\u00e1csy P, Cs\u00e9p\u00e1nyi-K\u00f6mi R (2025) Long COVID syndrome in children: neutrophilic granulocyte dysfunction and its correlation with disease severity. Pediatr Res 98:301\u2013313","journal-title":"Pediatr Res"},{"key":"6789_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1081718","volume":"13","author":"SL Sommen","year":"2022","unstructured":"Sommen SL, Havdal LB, Selvakumar J, Einvik G, Leegaard TM, Lund-Johansen F, Michelsen AE, Mollnes TE, Stiansen-Sonerud T, Tjade T, Wyller VB, Berven LL (2022) Inflammatory markers and pulmonary function in adolescents and young adults 6 months after mild COVID-19. Front Immunol 13:1081718. https:\/\/doi.org\/10.3389\/fimmu.2022.1081718","journal-title":"Front Immunol"},{"key":"6789_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2025.103020","author":"PC Chen","year":"2026","unstructured":"Chen PC, Hsu Y-L, Lin C-Y, Liu X-L, Hsieh M-H, Tsai H-J, Kuo W-S, Kao H-F, Wang S-D, Ho Y-S, Cai C-Y (2026) Anti-nucleocapsid antibody levels reflect post-acute sequelae of COVID-19 symptom burden in children. J Infect Public Health. https:\/\/doi.org\/10.1016\/j.jiph.2025.103020","journal-title":"J Infect Public Health"},{"key":"6789_CR27","doi-asserted-by":"publisher","first-page":"2301761","DOI":"10.1183\/13993003.01761-2023","volume":"59","author":"L Sigfrid","year":"2022","unstructured":"Sigfrid L, Seylanova N, Munblit D, Aiyegbusi OL, Hughes SE, Williamson PR, Warner JO et al (2022) Core outcome measurement set for post-COVID-19 condition in children and young people: an international Delphi consensus. Eur Respir J 59:2301761. https:\/\/doi.org\/10.1183\/13993003.01761-2023","journal-title":"Eur Respir J"},{"key":"6789_CR28","volume":"19","author":"JC Smith","year":"2023","unstructured":"Smith JC, Young ME, Lee K, Kim S, Hernandez R, Pang JL (2023) Metabolic signatures of long COVID in pediatric patients. Metabolomics 19:129","journal-title":"Metabolomics"},{"key":"6789_CR29","first-page":"e2010","volume":"104","author":"LL Chan","year":"2024","unstructured":"Chan LL, Kang Y, Pang DW, Zhong W, Obiero J, Kelly D, Kelleher KJ (2024) Persistent neurological deficits in children after COVID-19: a multicenter study. Neurology 104:e2010\u2013e2021","journal-title":"Neurology"},{"key":"6789_CR30","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/s41590-023-01724-6","volume":"25","author":"PA Mudd","year":"2023","unstructured":"Mudd PA, Kuo G, Presti RM, Hu X, Davis ME (2023) Adaptive immune responses drive persistent symptoms in post-acute SARS-CoV-2 infection. Nat Immunol 25:210\u2013221. https:\/\/doi.org\/10.1038\/s41590-023-01724-6","journal-title":"Nat Immunol"},{"key":"6789_CR31","volume":"134","author":"GH Williams","year":"2024","unstructured":"Williams GH, Marshall JC, Lowe DJ, Hastie CE, Shah AS (2024) Microvascular dysfunction and brain-fog in long-COVID: evidence of fibrinogen-mediated clotting-protein excess. J Clin Invest 134:e170123","journal-title":"J Clin Invest"},{"key":"6789_CR32","first-page":"1202","volume":"384","author":"J Kaiser","year":"2024","unstructured":"Kaiser J (2024) Clotting proteins linked to long-COVID\u2019s \u201cbrain-fog.\u201d Science 384:1202\u20131203","journal-title":"Science"},{"key":"6789_CR33","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1001\/jamapediatrics.2024.6206","volume":"179","author":"ND Ford","year":"2025","unstructured":"Ford ND, Vahratian A, Pratt CQ, Yousaf AR, Gregory CO, Saydah S (2025) Long COVID prevalence and associated activity limitation in US children. JAMA Pediatr 179:471\u2013473. https:\/\/doi.org\/10.1001\/jamapediatrics.2024.6206","journal-title":"JAMA Pediatr"},{"key":"6789_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1081718","volume":"13","author":"SL Sommen","year":"2023","unstructured":"Sommen SL, Havdal LB, Selvakumar J, Einvik G, Leegaard TM, Lund-Johansen F, Michelsen AE, Mollnes TE, Stiansen-Sonerud T, Tjade T, Wyller VBB, Berven LL (2023) Inflammatory markers and pulmonary function in adolescents and young adults 6 months after mild COVID-19. Front Immunol 13:1081718. https:\/\/doi.org\/10.3389\/fimmu.2022.1081718","journal-title":"Front Immunol"},{"key":"6789_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100663","volume":"3","author":"C Schulthei\u00df","year":"2022","unstructured":"Schulthei\u00df C, Willscher E, Paschold L, Gottschick C, Klee B, Henkes S-S, Bosurgi L, Dutzmann J, Sedding D, Frese T, Girndt M, H\u00f6ll JI, Gekle M, Mikolajczyk R, Binder M (2022) The IL-1\u03b2, IL-6 and TNF cytokine triad is associated with post-acute sequelae of COVID-19. Cell Rep Med 3:100663. https:\/\/doi.org\/10.1016\/j.xcrm.2022.100663","journal-title":"Cell Rep Med"},{"key":"6789_CR36","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3390\/life12020285","volume":"12","author":"V Fainardi","year":"2022","unstructured":"Fainardi V, Meoli A, Chiopris G, Motta M, Skenderaj K, Grandinetti R, Bergomi A, Antodaro F, Zona S, Esposito S (2022) Long COVID in children and adolescents. Life 12:285. https:\/\/doi.org\/10.3390\/life12020285","journal-title":"Life"},{"key":"6789_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s13052-024-01587-z","volume":"50","author":"C Luo","year":"2024","unstructured":"Luo C, Chen W, Cai J, He Y (2024) The mechanisms of milder clinical symptoms of COVID-19 in children compared to adults. Ital J Pediatr 50:28. https:\/\/doi.org\/10.1186\/s13052-024-01587-z","journal-title":"Ital J Pediatr"},{"key":"6789_CR38","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1038\/s41590-023-01560-8","volume":"24","author":"MJ Lee","year":"2023","unstructured":"Lee MJ, Blish CA (2023) Defining the role of natural killer cells in COVID-19. Nat Immunol 24:1628\u20131638. https:\/\/doi.org\/10.1038\/s41590-023-01560-8","journal-title":"Nat Immunol"},{"key":"6789_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41390-023-02549-7","author":"GA Rotulo","year":"2023","unstructured":"Rotulo GA, Palma P (2023) Understanding COVID-19 in children: immune determinants and post-infection conditions. Pediatr Res. https:\/\/doi.org\/10.1038\/s41390-023-02549-7","journal-title":"Pediatr Res"},{"issue":"1","key":"6789_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-024-10222-5","volume":"24","author":"C Tilikete","year":"2024","unstructured":"Tilikete C, Zamali I, Meddeb Z, Kharroubi G, Marzouki S, Dhaouadi T, Ben Hmid A, Samoud S, Galai Y, Charfeddine S, Abid L, Abdessalem S, Bettaieb J, Hamzaoui S, Bouslama K, Ben Ahmed M (2024) Exploring the landscape of symptom-specific inflammatory cytokines in post-COVID syndrome patients. BMC Infect Dis 24(1):1337. https:\/\/doi.org\/10.1186\/s12879-024-10222-5","journal-title":"BMC Infect Dis"},{"key":"6789_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2021.11075","volume":"159","author":"SKS Bhagavatham","year":"2022","unstructured":"Bhagavatham SKS, Potikuri D, Sivaramakrishnan V (2022) Adenosine deaminase and cytokines associated with infectious diseases as risk factors for inflammatory arthritis and methotrexate as a potential prophylactic agent. Med Hypotheses 159:110751. https:\/\/doi.org\/10.1016\/j.mehy.2021.11075","journal-title":"Med Hypotheses"},{"key":"6789_CR42","doi-asserted-by":"publisher","first-page":"10978","DOI":"10.3390\/ijms241310978","volume":"24","author":"A Silvestrini","year":"2023","unstructured":"Silvestrini A, Meucci E, Ricerca BM, Mancini A (2023) Total antioxidant capacity: biochemical aspects and clinical significance. Int J Mol Sci 24:10978. https:\/\/doi.org\/10.3390\/ijms241310978","journal-title":"Int J Mol Sci"},{"key":"6789_CR43","doi-asserted-by":"publisher","first-page":"611","DOI":"10.2174\/1389203721666200214111816","volume":"21","author":"S Ramani","year":"2020","unstructured":"Ramani S, Pathak A, Dalal V, Paul A, Biswas S (2020) Oxidative stress in autoimmune diseases: an under-dealt malice. Curr Protein Pept Sci 21:611\u2013621. https:\/\/doi.org\/10.2174\/1389203721666200214111816","journal-title":"Curr Protein Pept Sci"},{"key":"6789_CR44","doi-asserted-by":"publisher","first-page":"13140","DOI":"10.3390\/ijms241713140","volume":"24","author":"A Jedrzejewska","year":"2023","unstructured":"Jedrzejewska A, Kawecka A, Braczko A, Romanowska-Kocejko M, Stawarska K, Deptu\u0142a M, Zawrzykraj M, Franczak M, Krol O, Harasim G, Walczak I, Piku\u0142a M, Hellmann M, Kutryb-Zaj\u0105c B (2023) Changes in adenosine deaminase activity and endothelial dysfunction after mild coronavirus disease-2019. Int J Mol Sci 24:13140. https:\/\/doi.org\/10.3390\/ijms241713140","journal-title":"Int J Mol Sci"},{"key":"6789_CR45","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1016\/j.jtha.2023.04.039","volume":"21","author":"L Nicolai","year":"2023","unstructured":"Nicolai L, Kaiser R, Stark K (2023) Thrombo-inflammation in long COVID \u2014 the elusive key to post-infection sequelae? J Thromb Haemost 21:2020\u20132031. https:\/\/doi.org\/10.1016\/j.jtha.2023.04.039","journal-title":"J Thromb Haemost"},{"issue":"2","key":"6789_CR46","doi-asserted-by":"publisher","first-page":"231","DOI":"10.5114\/ceh.2021.107566","volume":"7","author":"S Hegazy","year":"2021","unstructured":"Hegazy S, Elsabaawy M, Eltabakh M, Hammad R, Bedair H (2021) CD62P (P-selectin) expression as a platelet activation marker in patients with liver cirrhosis with and without cholestasis. Clin Exp Hepatol 7(2):231\u2013240. https:\/\/doi.org\/10.5114\/ceh.2021.107566","journal-title":"Clin Exp Hepatol"},{"issue":"6","key":"6789_CR47","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.tem.2023.03.002","volume":"34","author":"S Turner","year":"2023","unstructured":"Turner S, Khan MA, Putrino D, Woodcock A, Kell DB, Pretorius E (2023) Long COVID: pathophysiological factors and abnormalities of coagulation. Trends Endocrinol Metab 34(6):321\u2013344. https:\/\/doi.org\/10.1016\/j.tem.2023.03.002","journal-title":"Trends Endocrinol Metab"},{"key":"6789_CR48","doi-asserted-by":"publisher","first-page":"12891","DOI":"10.3390\/ijms232112891","volume":"23","author":"DB Kell","year":"2022","unstructured":"Kell DB, Pretorius E (2022) A central role for amyloid fibrin microclots in long COVID\/PASC. Int J Mol Sci 23:12891. https:\/\/doi.org\/10.3390\/ijms232112891","journal-title":"Int J Mol Sci"},{"issue":"8","key":"6789_CR49","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.29887","volume":"96","author":"AR Thierry","year":"2024","unstructured":"Thierry AR, Salmon D (2024) Inflammation-, immunothrombosis-, and autoimmune-feedback loops may lead to persistent neutrophil self-stimulation in long COVID. J Med Virol 96(8):e29887. https:\/\/doi.org\/10.1002\/jmv.29887","journal-title":"J Med Virol"},{"key":"6789_CR50","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.10565006","volume":"95","author":"A Shafqat","year":"2023","unstructured":"Shafqat A, Patel R, Al Duhailib Z et al (2023) Neutrophil extracellular traps and long COVID. J Med Virol 95:e10565006. https:\/\/doi.org\/10.1002\/jmv.10565006","journal-title":"J Med Virol"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-026-06789-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-026-06789-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-026-06789-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T05:37:26Z","timestamp":1777354646000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-026-06789-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,16]]},"references-count":50,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["6789"],"URL":"https:\/\/doi.org\/10.1007\/s00431-026-06789-7","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,16]]},"assertion":[{"value":"21 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr Danilo Buonsenso has received funds to study long covid from Pfizer and Roche.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"132"}}